Liapi E - Search Results

1

Novel local therapies in hepatocellular carcinoma.

Liapi E, Geschwind JH. Liapi E, et al. Clin Liver Dis (Hoboken). 2013 Jan 23;1(6):209-211. doi: 10.1002/cld.131. eCollection 2012 Dec. Clin Liver Dis (Hoboken). 2013. PMID: 31186889 Free PMC article. Review. No abstract available.

2

Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma.

Liapi E, Geschwind JF. Liapi E, et al. Liver Cancer. 2012 Nov;1(3-4):201-15. doi: 10.1159/000343835. Liver Cancer. 2012. PMID: 24159585 Free PMC article. Review.

3

Intra-arterial therapies for hepatocellular carcinoma: where do we stand?

Liapi E, Geschwind JF. Liapi E, et al. Ann Surg Oncol. 2010 May;17(5):1234-46. doi: 10.1245/s10434-010-0977-4. Epub 2010 Apr 20. Ann Surg Oncol. 2010. PMID: 20405328 Review.

4

Multidetector CT of hepatocellular carcinoma.

Kamel IR, Liapi E, Fishman EK. Kamel IR, et al. Among authors: liapi e. Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):63-89. doi: 10.1016/j.bpg.2004.10.005. Best Pract Res Clin Gastroenterol. 2005. PMID: 15757805 Review.

5

The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.

Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF. Kamel IR, et al. Among authors: liapi e. J Vasc Interv Radiol. 2006 Mar;17(3):505-12. doi: 10.1097/01.RVI.0000200052.02183.92. J Vasc Interv Radiol. 2006. PMID: 16567675

6

Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?

Georgiades C, Geschwind JF, Harrison N, Hines-Peralta A, Liapi E, Hong K, Wu Z, Kamel I, Frangakis C. Georgiades C, et al. Among authors: liapi e. Radiology. 2012 Oct;265(1):115-23. doi: 10.1148/radiol.12112264. Epub 2012 Aug 13. Radiology. 2012. PMID: 22891361 Free PMC article.

7

Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma.

Kamel IR, Reyes DK, Liapi E, Bluemke DA, Geschwind JF. Kamel IR, et al. Among authors: liapi e. J Vasc Interv Radiol. 2007 Jan;18(1 Pt 1):49-56. doi: 10.1016/j.jvir.2006.10.005. J Vasc Interv Radiol. 2007. PMID: 17296704

8

Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience.

Buijs M, Vossen JA, Frangakis C, Hong K, Georgiades CS, Chen Y, Liapi E, Geschwind JF. Buijs M, et al. Among authors: liapi e. Radiology. 2008 Oct;249(1):346-54. doi: 10.1148/radiol.2483071902. Radiology. 2008. PMID: 18796686 Free PMC article.

9

Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geschwind JF. Kamel IR, et al. Among authors: liapi e. Radiology. 2009 Feb;250(2):466-73. doi: 10.1148/radiol.2502072222. Radiology. 2009. PMID: 19188315 Free PMC article.

10

Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?

Loffroy R, Lin M, Yenokyan G, Rao PP, Bhagat N, Noordhoek N, Radaelli A, Blijd J, Liapi E, Geschwind JF. Loffroy R, et al. Among authors: liapi e. Radiology. 2013 Feb;266(2):636-48. doi: 10.1148/radiol.12112316. Epub 2012 Nov 9. Radiology. 2013. PMID: 23143027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters